R. Varga

Antiarrhythmic and cardiac electrophysiological effects of SZV-270, a novel compound with combined Class I/B and Class III effects, in rabbits and dogs.

P. Mátyus, N. Nagy, L. Virág, 2020, Canadian journal of physiology and pharmacology.

In vivo and cellular antiarrhythmic and cardiac electrophysiological effects of desethylamiodarone in dog cardiac preparations

N. Nagy, L. Virág, Z. Aigner, 2022, British journal of pharmacology.

The Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo Experiments

J. Papp, J. Levijoki, N. Nagy, 2016, PloS one.

Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion

Z. Giricz, P. Ferdinandy, Z. Zádori, 2020, Cells.

Mexiletine-like cellular electrophysiological effects of GS967 in canine ventricular myocardium

L. Virág, T. Mercan, A. Varró, 2021, Scientific Reports.

Is Selective Late Na+ Current Inhibition Different From Class I/B Antiarrhythmic Action? Comparison of The Effects of GS967 to Mexiletine in Canine Ventricular Myocardium

L. Virág, T. Mercan, A. Varró, 2021 .